Vegetos

References

Aanouz I et al (2020) ‘Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations’, Journal of Biomolecular Structure and Dynamics, pp. 1–9. Available at: https://doi.org/10.1080/07391102.2020.1758790


Abdelli I et al (2020) ‘In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria’, Journal of biomolecular structure & dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020.1763199


Ahmad S et al (2021) ‘Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research’, Frontiers in pharmacology, 11, p. 578970. Available at: https://doi.org/10.3389/fphar.2020.578970


Alagu Lakshmi S et al (2020) ‘Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach’, Journal of Biomolecular Structure and Dynamics, pp. 1–16. Available at: https://doi.org/10.1080/07391102.2020.1778537


Alam S et al (2021) ‘Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.’, Frontiers in pharmacology, 12, p. 671498. Available at: https://doi.org/10.3389/fphar.2021.671498


Al-kuraishy HM et al (2022) ‘Traditional herbs against COVID-19: back to old weapons to combat the new pandemic’, European Journal of Medical Research, 27(1), p. 186. Available at: https://doi.org/10.1186/s40001-022-00818-5


Alrasheid AA, Babiker MY, Awad TA (2021) ‘Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis’, In Silico Pharmacology, 9(1), p. 10. Available at: https://doi.org/10.1007/s40203-020-00073-8


Anand U et al (2019) ‘A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery’, Metabolites, 9(11), p. 258. Available at: https://doi.org/10.3390/metabo9110258


Ang L et al (2020) ‘Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines’, Integrative Medicine Research, 9(2), p. 100407. Available at: https://doi.org/10.1016/j.imr.2020.100407


Aouidate A et al (2020) ‘Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation’, Journal of Biomolecular Structure and Dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020.1779130


Atanasov AG et al (2015) ‘Discovery and resupply of pharmacologically active plant-derived natural products: A review’, Biotechnology advances. 2015/08/15, 33(8), pp. 1582–1614. Available at: https://doi.org/10.1016/j.biotechadv.2015.08.001


Azim KF et al (2020) ‘Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach’, Informatics in Medicine Unlocked. 2020/06/09, 20, p. 100367. Available at: https://doi.org/10.1016/j.imu.2020.100367


Balkrishna A et al (2020) ‘Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines’, Journal of inflammation research, 13, pp. 1219–1243. Available at: https://doi.org/10.2147/JIR.S286199


Balkrishna A, Khandrika L, Varshney A (2021) ‘Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f.and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish’, Frontiers in Pharmacology, 12. Available at: https://doi.org/10.3389/fphar.2021.635510


Borkotoky S, Banerjee M (2020) ‘A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)’, Journal of Biomolecular Structure and Dynamics, pp. 1–11. Available at: https://doi.org/10.1080/07391102.2020.1774419


Calder PC (2020) ‘Nutrition, immunity and COVID-19’, BMJ Nutrition, Prevention & Health [Preprint]. Available at: https://doi.org/10.1136/bmjnph-2020-000085


Chikhale RV, Sinha SK et al (2020) ‘In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19’, Journal of Biomolecular Structure and Dynamics, pp. 1–15. Available at: https://doi.org/10.1080/07391102.2020.1784289


Chikhale RV, Gurav SS et al (2020) ‘Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1778539


Chowdhury P (2020) ‘In silico investigation of phytoconstituents from Indian medicinal herb “Tinospora cordifolia (giloy)” against SARS-CoV-2 (COVID-19) by molecular dynamics approach’, Journal of Biomolecular Structure and Dynamics, pp. 1–18. Available at: https://doi.org/10.1080/07391102.2020.1803968


Clementi N et al (2021) ‘Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro’, Pharmacological research. 2020/10/20, 163, p. 105255. Available at: https://doi.org/10.1016/j.phrs.2020.105255


ClinicalTrials.gov Identifier: NCT04322682 (2021) Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19)


ClinicalTrials.gov Identifier : NCT04377789 (2021) Effect of Quercetin on Prophylaxis and Treatment of COVID-19


ClinicalTrials.gov Identifier: NCT04404218 (2020) The Açaí Berry COVID-19 Anti-Inflammation Trial (ACAI)


ClinicalTrials.gov Identifier: NCT04542993 (2020) Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy (Reszinate)


ClinicalTrials.gov Identifier : NCT04621903 (2020) A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19


ClinicalTrials.gov ID NCT04716647 (2021) Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research. Available at: https://www.clinicaltrials.gov/study/NCT04716647


Costa AN et al (2020) ‘Constituents of buriti oil (Mauritia flexuosa L.) like inhibitors of the SARS-Coronavirus main peptidase: an investigation by docking and molecular dynamics’, Journal of Biomolecular Structure and Dynamics, pp. 1–8. Available at: https://doi.org/10.1080/07391102.2020.1778538


Das K (2022) ‘Herbal plants as immunity modulators against COVID-19: A primary preventive measure during home quarantine’, Journal of Herbal Medicine, 32, p. 100501. Available at: https://doi.org/10.1016/j.hermed.2021.100501


Das P et al (2020a) ‘In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis’, Journal of Biomolecular Structure and Dynamics, pp. 1–16. Available at: https://doi.org/10.1080/07391102.2020a.1796799


Das S et al (2020b) ‘An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study’, Journal of Biomolecular Structure and Dynamics, pp. 1–11. Available at: https://doi.org/10.1080/07391102.2020b.1763201


Dave GS et al (2020) ‘Highaffinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection’, Phytotherapy Research [Preprint]. Available at: https://doi.org/10.1002/ptr.6796


Davies M et al (2020) ‘Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment’, Drug safety, 43(7), pp. 645–656. Available at: https://doi.org/10.1007/s40264-020-00952-1


Dermawan D, Prabowo BA, Rakhmadina CA (2021) ‘In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M(pro)) and spike (S) receptor’, Informatics in medicine unlocked. 2021/06/24, 25, p. 100645. Available at: https://doi.org/10.1016/j.imu.2021.100645


Dutta M et al (2021) ‘Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach’, Frontiers in molecular biosciences, 8, p. 625391. Available at: https://doi.org/10.3389/fmolb.2021.625391


Enmozhi SK et al (2020) ‘Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach’, Journal of Biomolecular Structure and Dynamics, pp. 1–7. Available at: https://doi.org/10.1080/07391102.2020.1760136


Frederico ÉHFF et al (2017) ‘ANTI-VIRAL EFFECTS OF MEDICINAL PLANTS IN THE MANAGEMENT OF DENGUE: A SYSTEMATIC REVIEW’, African journal of traditional, complementary, and alternative medicines: AJTCAM, 14(4 Suppl), pp. 33–40. Available at: https://doi.org/10.21010/ajtcam.v14i4S.5


Gandhi AJ et al (2020) ‘An Ayurvedic Perspective along with in Silico Study of the Drugs for the Management of Sars-Cov-2’, Journal of Ayurveda and Integrative Medicine [Preprint]. Available at: https://doi.org/10.1016/j.jaim.2020.07.002


Ganjhu RK et al (2015) ‘Herbal plants and plant preparations as remedial approach for viral diseases’, Virusdisease. 2015/09/03, 26(4), pp. 225–236. Available at: https://doi.org/10.1007/s13337-015-0276-6


Gautam S et al (2020) ‘Immunity against COVID-19: Potential role of Ayush Kwath’, Journal of Ayurveda and Integrative Medicine [Preprint]. Available at: https://doi.org/https://doi.org/10.1016/j.jaim.2020.08.003


Ghosh R et al (2020a) ‘Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study’, Journal of Biomolecular Structure and Dynamics, pp. 1–13. Available at: https://doi.org/10.1080/07391102.2020.1779818


Ghosh R et al (2020b) ‘Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches’, Journal of Biomolecular Structure and Dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020.1802347


Gorla US et al (2020) ‘Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation’, Combinatorial Chemistry & High Throughput Screening [Preprint]. Available at: https://doi.org/10.2174/1386207323999200818162706


Gupta MK et al (2020a) ‘In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel’, Journal of Biomolecular Structure and Dynamics, pp. 1–11. Available at: https://doi.org/10.1080/07391102.2020a.1751300


Gupta S et al (2020b) ‘Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020b.1776157


Gurung AB et al (2020) ‘Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach’, Life sciences, 255, p. 117831. Available at: https://doi.org/10.1016/j.lfs.2020.117831


Gyebi GA et al (2020) ‘Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants’, Journal of Biomolecular Structure and Dynamics, pp. 1–13. Available at: https://doi.org/10.1080/07391102.2020.1764868


Hillen HS et al (2020) ‘Structure of replicating SARS-CoV-2 polymerase’, Nature [Preprint]. Available at: https://doi.org/10.1038/s41586-020-2368-8


Hoffmann M et al (2020) ‘SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor’, Cell. 2020/03/05, 181(2), pp. 271–280.e8. Available at: https://doi.org/10.1016/j.cell.2020.02.052


Huang C et al (2020) ‘Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China’, The Lancet, 395(10223), pp. 497–506. Available at: https://doi.org/10.1016/S0140-6736(20)30183-5


Islam R et al (2020) ‘A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1761883


Jahan I, Onay A (2020) ‘Potentials of plant-based substance to inhabit and probable cure for the covid-19’, Turkish Journal of Biology [Preprint]. Available at: https://doi.org/10.3906/biy-2005-114


Jin Z et al (2020) ‘Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors’, Nature [Preprint]. Available at: https://doi.org/10.1038/s41586-020-2223-y


Joshi RS et al (2020a) ‘Discovery ofpotential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease’, Journal of biomolecular structure & dynamics, pp. 1–16. Available at: https://doi.org/10.1080/07391102.2020a.1760137


Joshi T et al (2020b) ‘In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking’, European review for medical and pharmacological sciences [Preprint]. Available at: https://doi.org/10.26355/eurrev_2020b04_21036


Kar P et al (2020) ‘Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1780947


Kaur V et al (2018) ‘Pharmacotherapeutic potential of phytochemicals: Implications in cancer chemoprevention and future perspectives’, Biomedicine & Pharmacotherapy, 97, pp. 564–586. Available at: https://doi.org/https://doi.org/10.1016/j.biopha.2017.10.124


Kiran G et al (2020) ‘In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein’, Journal of Ayurveda and integrative medicine, pp. S0975-9476(20)30024–3. Available at: https://doi.org/10.1016/j.jaim.2020.05.009


Krupanidhi S et al (2020) ‘Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study’, Journal of Biomolecular Structure and Dynamics, pp. 1–5. Available at: https://doi.org/10.1080/07391102.2020.1787226


Kumar A et al (2020a) ‘Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches’, Journal of Biomolecular Structure and Dynamics, pp. 1–11. Available at: https://doi.org/10.1080/07391102.2020a.1772112


Kumar Singh S, Rajoria K, Sharma S (2020) ‘Principles of Rajayakshma management for COVID-19’, Journal of Ayurveda and Integrative Medicine [Preprint]. Available at: https://doi.org/https://doi.org/10.1016/j.jaim.2020.08.002


Kumar S et al (2020b) ‘Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication’, Phytomedicine, p. 153317. Available at: https://doi.org/10.1016/j.phymed.2020b.153317


Kumar V et al (2020c) ‘Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity’, Journal of Biomolecular Structure and Dynamics, pp. 1–13. Available at: https://doi.org/10.1080/07391102.2020c.1772108


Kwofie SK et al (2019) ‘Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24’, Computers in Biology and Medicine, 113, p. 103414. Available at: https://doi.org/10.1016/j.compbiomed.2019.103414


Kwon S et al (2020) ‘Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review’, Integrative Medicine Research, 9(3), p. 100480. Available at: https://doi.org/10.1016/j.imr.2020.100480


Lionis, C. et al. (2021) ‘A mixture of essential oils from three Cretan Aromatic Plants (thyme, Greek sage and Cretan dittany, CAPeo) inhibits SASR-CoV-2 proliferation: in vitroevidence and a Proof-of-Concept intervention study in mild ambulatory COVID-19-pos’,medRxiv, p. 2021.01.11.20248947. Available at: https://doi.org/10.1101/2021.01.11.20248947


Lung J et al (2020) ‘The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase’, Journal of medical virology, p. https://doi.org/10.1002/jmv.25761. Available at: https://doi.org/10.1002/jmv.25761


Majumder R, Mandal M (2020) ‘Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach’, Journal of Biomolecular Structure and Dynamics, pp. 1–16. Available at: https://doi.org/10.1080/07391102.2020.1817787


Marinella MA (2020) ‘Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19’, International journal of clinical practice, pp. e13535–e13535. Available at: https://doi.org/10.1111/ijcp.13535


Maurya R, Handa SS (1998) ‘Tinocordifolin, a sesquiterpene from Tinospora cordifolia1R.R.L. communication number 22501’, Phytochemistry, 49(5), pp. 1343–1345. Available at: https://doi.org/https://doi.org/10.1016/S0031-9422(98)00093-4


Maurya VK et al (2020) ‘Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor’, VirusDisease, pp. 1–15. Available at: https://doi.org/10.1007/s13337-020-00598-8


Mehrbod P et al (2018) ‘South African medicinal plant extracts active against influenza A virus’, BMC complementary and alternative medicine, 18(1), p. 112. Available at: https://doi.org/10.1186/s12906-018-2184-y


Morse JS et al (2020) ‘Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV’, Chembiochem: a European journal of chemical biology. 2020/02/25, 21(5), pp. 730–738. Available at: https://doi.org/10.1002/cbic.202000047


Mouffouk C et al (2021) ‘Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)’, European journal of pharmacology. 2020/11/27, 891, p. 173759. Available at: https://doi.org/10.1016/j.ejphar.2020.173759


Mpiana PT et al (2020) ‘Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study’, Chemical Physics Letters, 754, p. 137751. Available at: https://doi.org/10.1016/j.cplett.2020.137751


Mukherjee PK et al (2022) ‘Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications’, Phytomedicine, 98, p. 153930. Available at: https://doi.org/10.1016/j.phymed.2022.153930


Murugan NA, Pandian CJ, Jeyakanthan J (2020) ‘Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1777901


Murugesan S et al (2021) ‘Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study’, Computers in biology and medicine, 136, p. 104683. Available at: https://doi.org/10.1016/j.compbiomed.2021.104683


Narkhede RR et al (2020) ‘Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences’, Natural products and bioprospecting, pp. 1–10. Available at: https://doi.org/10.1007/s13659-020-00253-1


Nasir Ahmed M, Hughes K (2022) ‘Role of ethno-phytomedicine knowledge in healthcare of COVID-19: advances in traditional phytomedicine perspective’, Beni-Suef University Journal of Basic and Applied Sciences, 11(1), p. 96. Available at: https://doi.org/10.1186/s43088-022-00277-1


Natesh J et al (2021) ‘Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation’, Computers in biology and medicine. 2021/04/20, 133, p. 104383. Available at: https://doi.org/10.1016/j.compbiomed.2021.104383


Ni Let al (2020) ‘Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19’, Frontiers of medicine. 2020/03/13, 14(2), pp. 210–214. Available at: https://doi.org/10.1007/s11684-020-0757-x


Ogunrinola OO, Kanmodi RI, Ogunrinola OA (2022) ‘Medicinal plants as immune booster in the palliative management of viral diseases: A perspective on coronavirus’, Food Frontiers, 3(1), pp. 83–95. Available at: https://doi.org/10.1002/fft2.107


Oso BJ, Adeoye AO, Olaoye IF (2020) ‘Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1813630


Pandey A et al (2020) ‘Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements’, Life Sciences [Preprint]. Available at: https://doi.org/10.1016/j.lfs.2020.117883


Pandeya KB, Ganeshpurkar A, Mishra MK (2020) ‘Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana’, Medical Hypotheses. 2020/06/01, 144, p. 109905. Available at: https://doi.org/10.1016/j.mehy.2020.109905


Peng X et al (2020) ‘Transmission routes of 2019-nCoV and controls in dental practice’, International Journal of Oral Science, 12(1), p. 9. Available at: https://doi.org/10.1038/s41368-020-0075-9


Polansky H, Lori G (2020) ‘Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection’, International journal of antimicrobial agents. 2020/04/10, 55(6), p. 105971. Available at: https://doi.org/10.1016/j.ijantimicag.2020.105971


Popoola TD et al (2022) ‘West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19’, DARU Journal of Pharmaceutical Sciences, 30(1), pp. 191–210. Available at: https://doi.org/10.1007/s40199-022-00437-9


Prajapat M et al (2020) ‘Drug targets for corona virus: A systematic review’, Indian journal of pharmacology. 2020/03/11, 52(1), pp. 56–65. Available at: https://doi.org/10.4103/ijp.IJP_115_20


Prasanth DSNBK et al (2020) ‘In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2’, Journal of Biomolecular Structure and Dynamics, pp. 1–15. Available at: https://doi.org/10.1080/07391102.2020.1779129


Rolta R et al (2020) ‘In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly’, Journal of Biomolecular Structure and Dynamics, pp. 1–18. Available at: https://doi.org/10.1080/07391102.2020.1804457


Runfeng L et al (2020) ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)’, Pharmacological Research, 156, p. 104761. Available at: https://doi.org/10.1016/j.phrs.2020.104761


Selvaraj C et al (2020) ‘Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1778535


Sharma A et al (2020) ‘In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15proteins of SARS-CoV-2’, Journal of Biomolecular Structure and Dynamics, pp. 1–15. Available at: https://doi.org/10.1080/07391102.2020.1808077


Sharma P, Shanavas A (2020) ‘Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis’, Journal of Biomolecular Structure and Dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1794970


Shivanika C et al (2020) ‘Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease’, Journal of Biomolecular Structure and Dynamics, pp. 1–27. Available at: https://doi.org/10.1080/07391102.2020.1815584


Shree P et al (2020) ‘Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study’, Journal of Biomolecular Structure and Dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020.1810778


Singh P et al (2020a) ‘Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review’, Plant Foods for Human Nutrition, 75(4), pp. 458–466. Available at: https://doi.org/10.1007/s11130-020-00861-9


Singh P et al (2021a) ‘In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2’, Molecular biology research communications, 10(3), pp. 131–140. Available at: https://doi.org/10.22099/mbrc.2021a.40367.1621


Singh P, Tripathi KM, Shrivastava R (2021b) In silico identification of linear B-cell epitope in Coronavirus 2019 (SARS-CoV-2) surface glycoprotein: a prospective towards peptide vaccine. Minerva Biotechnol Biomol Res 33(1):29–65


Singh P et al (2022) ‘Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India’, Microbial Pathogenesis, 164, p. 105404. Available at: https://doi.org/10.1016/j.micpath.2022.105404


Singh S et al (2020b) ‘Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis’, Journal of Biomolecular Structure and Dynamics, pp. 1–16. Available at: https://doi.org/10.1080/07391102.2020b.1796810


Sinha SK, Shakya A et al (2020) ‘An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets’, Journal of biomolecular structure & dynamics, pp. 1–12. Available at: https://doi.org/10.1080/07391102.2020.1762741


Sinha SK, Prasad SK et al (2020) ‘Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study’, Journal of Biomolecular Structure and Dynamics, pp. 1–15. Available at: https://doi.org/10.1080/07391102.2020.1779132


Soleymani S et al (2022) ‘COVID-19: General Strategies for Herbal Therapies’, Journal of Evidence-Based Integrative Medicine, 27, p. 2515690X2110536. Available at: https://doi.org/10.1177/2515690X211053641


Tahir ul, Qamar M et al (2020) ‘Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants’, Journal of Pharmaceutical Analysis [Preprint]. Available at: https://doi.org/10.1016/j.jpha.2020.03.009


Tripathi MK, Singh P, Sharma S, Singh, Tej P et al (2020a) ‘Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor’, Journal of Biomolecular Structure and Dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020a.1790425


Tripathi MK, Singh P, Sharma S, Singh, Tej P et al (2020b) ‘Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor’, Journal of Biomolecular Structure and Dynamics, pp. 1–14. Available at: https://doi.org/10.1080/07391102.2020b.1790425


Tripathi MK et al (2022) ‘Identification of a promising inhibitor from Illicium verum (star anise) against the main protease of SARS-CoV-2: insights from the computational study.’, Journal of biomolecular structure & dynamics, pp. 1–17. Available at: https://doi.org/10.1080/07391102.2022.2112621


Umesh U et al (2020) ‘Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target’, Journal of Biomolecular Structure and Dynamics [Preprint]. Available at: https://doi.org/10.1080/07391102.2020.1763202


Vellingiri B et al (2020) ‘COVID-19: A promising cure for the global panic’, The Science of the total environment. 2020/04/04, 725, p. 138277. Available at: https://doi.org/10.1016/j.scitotenv.2020.138277


Wang Q et al (2020) ‘Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2’, Cell, 181(4), pp. 894–904. Available at: https://doi.org/10.1016/j.cell.2020.03.045


Wang Z et al (2022) ‘Bioactive natural products in COVID-19 therapy’, Frontiers in Pharmacology, 13. Available at: https://doi.org/10.3389/fphar.2022.926507


WHO (2020a) Corticosteroids for COVID-19: living guidance, 2 September 2020, https:https://apps.who.int/iris/handle/10665/334125 Available at:https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1 (Accessed: 23 September 2020)


WHO (2020b) Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations, https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations


WHO (2020c) WHO supports scientifically-proven traditional medicine, https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine


WHO (2023) COVID-19 Weekly Epidemiological Update: Edition 149 published 29 June 2023,:https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---29-june-2023


Wu C et al (2020) ‘Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods’, Acta Pharmaceutica Sinica. B [Preprint]. Available at: https://doi.org/10.1016/j.apsb.2020.02.008


XIA L et al (2021) ‘Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study’, Phytomedicine, 85, p. 153390. Available at: https://doi.org/10.1016/j.phymed.2020.153390


Xia S, Zhu Y et al (2020) ‘Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein’, Cellular & Molecular Immunology [Preprint]. Available at: https://doi.org/10.1038/s41423-020-0374-2


Xia S, Liu M et al (2020) ‘Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion’, Cell Research, 30(4), pp. 343–355. Available at: https://doi.org/10.1038/s41422-020-0305-x


Xiong W et al (2020) ‘Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial’, Integrative Medicine Research, p. 100489. Available at: https://doi.org/10.1016/j.imr.2020.100489